ciglitazone has been researched along with Fibrosarcoma in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, KH | 1 |
| Cho, YS | 1 |
| Park, JM | 1 |
| Yoon, SO | 1 |
| Kim, KW | 1 |
| Chung, AS | 1 |
1 other study available for ciglitazone and Fibrosarcoma
| Article | Year |
|---|---|
Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK.
Topics: Enzyme Activation; Enzyme Precursors; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Gela | 2007 |